RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer

Cancer Biomarkers

Volumn 10, Issue 1, 2011, Pages 13-26

  Sebova, Katarina ^a   Zmetakova, Iveta ^a   Bella, Vladimir ^b   Kajo, Karol ^c   Stankovicova, Iveta ^d   Kajabova, Viera ^a   Krivulcik, Tomas ^a   Lasabova, Zora ^c   Tomka, Miroslav ^a   Galbavy, Stefan ^b,e,f   Fridrichova, Ivana ^a  

^a CANCER RESEARCH INSTITUTE   (Slovakia)

^b ST ELIZABETH CANCER INSTITUTE   (Slovakia)

^c University Teaching Hospital in Martin   (Slovakia)

^d Physics and Informatics   (Slovakia)

^e St Elizabeth University College of Health and Social Sciences   (Slovakia)

^f Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

Author keywords

Breast cancer; CDH1 methylation; DNA hypermethylation; epigenetic biomarkers; quantitative assay; RASSF1A methylation

Indexed keywords

BIOLOGICAL MARKER; HISTONE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CANCER TISSUE; CDH1 GENE; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; GENE INACTIVATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; RASSF1A GENE; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

AGED; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; CADHERINS; CALIBRATION; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CASE-CONTROL STUDIES; DNA METHYLATION; EARLY DETECTION OF CANCER; EPIGENESIS, GENETIC; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REFERENCE STANDARDS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84856670345     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2012-0230     Document Type: Article

References (41)

1. J. Ferlay, D.M. Parkin and E. Steliarova-Foucher, Estimates of cancer incidence and mortality in Europe in 2008, Eur J Cancer 46 (2010), 765-781.
2. A. Fucito, C. Lucchetti, A. Giordano and G. Romano, Genetic and epigenetic alterations in breast cancer: what are the perspectives for clinical practice? Int J Biochem Cell Biol 40 (2008), 565-575. (Pubitemid 351288592)
3. P.A. Jones and S.B. Baylin, The fundamental role of epigenetic events in cancer, Nat Rev Genet 3 (2002), 415-428. (Pubitemid 34587077)
4. R.A. Hinshelwood and S.J. Clark, Breast cancer epigenetics: normal human mammary epithelial cells as a model system, J Mol Med 86 (2008), 1315-1328.
5. M. Widschwendter and P.A. Jones, DNA methylation and breast carcinogenesis, Oncogene 21 (2002), 5462-5482. (Pubitemid 34983482)
6. A. Agathanggelou, W.N. Cooper and F. Latif, Role of the Ras-association domain family 1 tumor suppressor gene in human cancers, Cancer Res 65 (2005), 3497-3508. (Pubitemid 40616319)
7. Z.G. Pan, V.I. Kashuba, X.Q. Liu, J.Y. Shao, R.H. Zhang, J.H. Jiang, C. Guo, E. Zabarovsky, I. Ernberg and Y.X. Zeng, High frequency somatic mutations in RASSF1A in nasopharyngeal carcinoma, Cancer Biol Ther 4 (2005), 1116-1122. (Pubitemid 41598567)
8. H. Donninger, M.D. Vos and G.J. Clark, The RASSF1A tumor suppressor, Journal of Cell Science 120 (2007), 3163-3172. (Pubitemid 350018407)
9. R. Dammann, G. Yang and G.P. Pfeifer, Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), a putativetumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers, Cancer Res 61 (2001), 3105-3109. (Pubitemid 32691961)
10. M. Shinozaki, D.S. Hoon, A.E. Giuliano, N.M. Hansen, H.J. Wang, R. Turner and B. Taback, Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis, Clin Cancer Res 11 (2005), 2156-2162. (Pubitemid 40490172)
11. W. Feng, R. Orlandi, N. Zhao, M.L. Carcangiu, E. Tagliabue, J. Xu, R.C. Bast, Jr. and Y. Yu, Tumor suppressor genes are frequently methylated in lymph node metastases of breast cancers, BMC Cancer 10 (2010), 378.
12. L. Pasquali, A. Bedeir, S. Ringquist, A. Styche, R. Bhargava and G. Trucco, Quantification of CpG island methylation in progressive breast lesions from normal to invasive carcinoma, Cancer Let 257 (2007), 136-144. (Pubitemid 47464705)
13. G. Berx and F. Van Roy, The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression, Breast Cancer Res 3 (2001), 289-293. (Pubitemid 32851157)
14. J.R. Graff, E. Gabrielson, H. Fujii, S.B. Baylin and J.G. Herman, Methylation patterns of the E-cadherin 5' CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression, J Biol Chem 275 (2000), 2727-2732. (Pubitemid 30082043)
15. C.P. Prasad, S. Mirza, G. Sharma, J. Prashad, S. DattaGupta, G. Rath and R. Ralhan, Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast, Life Sci 83 (2008), 318-325.
16. D. Zou, H.S. Yoon, D. Perez, R.J. Weeks, P. Guilford and B. Humar, Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia, J Pathol 18 (2009), 265-272.
17. B.J. Yoder, E.J. Wilkinson and N.A. Massoll, Molecular and morphologic distinctions between infiltrating ductal and lob-ular carcinoma of the breast, Breast J 13 (2007), 172-179. (Pubitemid 46280603)
18. F. Bertucci, B. Orsetti, V. Nègre, P. Finetti, C. Rougé, J.C. Ahomadegbe, F. Bibeau, M.C. Mathieu, I. Treilleux, J. Jacquemier, L. Ursule, A. Martinec, Q. Wang, J. Bénard, A. Puisieux, D. Birnbaum and C. Theillet, Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles, Oncogene 27 (2008), 5359-5372.
19. M. Harigopal, S.J. Shin, M.P. Murray, S.K. Tickoo, E. Brogi and P.P. Rosen, Aberrant E-cadherin staining patterns in invasive mammary carcinoma, World J Surg Oncol 3 (2005), 73.
20. E.A. Rakha, A. Patel, D.G. Powe, A. Benhasouna, A.R. Green, M.B. Lambros, J.S. Reis-Filho and I.O. Ellis, Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast, Am J Surg Pathol 34 (2010), 1472-1479.
21. J.R. Caldeira, E.C. Prando, F.C. Quevedo, F.A. Neto, C.A. Rainho and S.R. Rogatto, CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer, BMC Cancer 6 (2006), 48.
22. M.J. Duffy, R. Napieralski, J.W. Martens, P.N. Span, F. Spyratos, F.C. Sweep, N. Brunner, J.A. Foekens, M. Schmitt and EORTC PathoBiology Group, Methylated genes as new cancer biomarkers, Eur J Cancer 45 (2009), 335-346.
23. L.H. Sobin, M.K. Gospodarowicz and Ch. Wittekind, International Union Against Cancer (UICC), TNM classification of Malignant Tumours, 7th edition, Wiley-Blackwell, New York, 2009, pp. 181-193.
24. I.O. Ellis, S.J. Schnitt, X. Sastre-Garau, G. Bussolati, F.A. Tavassoli, V. Eusebi, J.L. Peterse, K. Mukai, L. Tabár, J. Jacquemier, C.J. Cornelisse and A.J. Sasco, Invasive breast carcinoma, in: Pathology and Genetics of Tumours of the Breast and Female Genital Organs, F.A. Tavassoli and P. Dev-ilee, eds, Lyon, IARC Press, France, 2003, pp. 13-59.
25. C.W. Elston and I.O. Ellis, Pathological prognostic factors in breast cancer I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up, Histopathology 19 (1991), 403-410.
26. M.J. Fackler, M. McVeigh, J. Mehrotra, M.A. Blum, J. Lange, A. Lapides, E. Garrett, P. Argani and S. Sukumar, Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer, Cancer Res 64 (2004), 4442-4452. (Pubitemid 38856915)
27. T. Swift-Scanlan, A. Blackford, P. Argani, S. Sukumar and M.J. Fackler, Two-color quantitative multiplex methylation-specific PCR, Biotechniques 40 (2006), 210-219. (Pubitemid 46542642)
28. R. Dammann, U. Schagdarsurengin, C. Seidel, M. Strunniko-va, M. Rastetter, K. Baier and G.P. Pfeifer, The tumor suppressor RASSF1A in human carcinogenesis: an update, Histol Histopathol 20 (2005), 645-663. (Pubitemid 40468282)
29. P.S. Yan, H. Shi, F. Rahmatpanah, T.H. Hsiau, A.H. Hsiau, Y.W. Leu, J.C. Liu and T.H. Huang, Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer, Cancer Res 63 (2003), 6178-6186. (Pubitemid 37255161)
30. J. R. Graff, J. G. Herman, S. Myöhänen, S. B. Baylin and P.M. Vertino, Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation, J Biol Chem 272 (1997), 22322-22329. (Pubitemid 27382868)
31. A. Celebiler Cavusoglu, A.I. Sevinc, S. Saydam, T. Canda, Z. Baskan, Y. Kilic and M. Sakizli, Promoter methylation and expression changes of CDH1 and P16 genes in invasive breast cancer and adjacent normal breast tissue, Neoplasma 57 (2010), 465-472.
32. I. Van der Auwera, C. Bovie, C. Svensson, X.B. Trinh, R. Limame, P. van Dam, S.J. van Laere, E.A. van Marck, L.Y. Dirix and P.B. Vermeulen, Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients, BMC Cancer 10 (2010), 97.
33. C.M. Wong, D.L. Anderton, S. Smith-Schneider, M.A. Wing, M.C. Greven and K.F. Arcaro, Quantitative analysis of promoter methylation in exfoliated epithelial cells isolated from breast milk of healthy women, Epigenetics 5 (2010), 645-655.
34. D.M. Euhus, D. Bu, S. Milchgrub, X.J. Xie, A. Bian, A.M. Leitch and C.M. Lewis, DNA methylation in benign breast epithelium in relation to age and breast cancer risk, Cancer Epidemiol Biomarkers Prev 17 (2008), 1051-1059.
35. M.H. Tao, P.G. Shields, J. Nie, A. Millen, C.B. Ambrosone, S.B. Edge, S.S. Krishnan, C. Marian, B. Xie, J. Winston, D. Vi-to, M. Trevisan and J.L. Freudenheim, DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study, Breast Cancer Res Treat 114 (2009), 559-568.
36. M.F. Fraga and M. Esteller, Epigenetics and aging: the targets and the marks, Trends Genet 23 (2007), 413-418. (Pubitemid 47088010)
37. J.Y. Wo, K. Chen, B.A. Neville, N.U. Lin and R.S. Punglia, Effect of very small tumor size on cancer-specific mortality in node-positive breast cancer, J Clin Oncol 29 (2011), 2619-2627.
38. E. Sunami, M. Shinozaki, M.S. Sim, S.L. Nguyen, A.T. Vu, A.E. Giuliano and D.S. Hoon, Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors, Breast Cancer Res 10 (2008), R46.
39. W. Feng, L. Shen, S. Wen, D.G. Rosen, J. Jelinek, X. Hu, S. Huan, M. Huang, J. Liu, A.A. Sahin, K.K. Hunt, R.C. Bast, Jr., Y. Shen, J.P. Issa and Y. Yu, Correlation between CpG methylation profiles and hormone receptor status in breast cancers, Breast Cancer Res 9 (2007), R57.
40. C. Sotiriou, S.Y. Neo, L.M. McShane, E.L. Korn, P.M. Long, A. Jazaeri, P. Martiat, S.B. Fox, A.L. Harris and E.T. Liu, Breast cancer classification and prognosis based on gene expression profiles from a population-based study, Proc Natl Acad Sci USA 100 (2003), 10393-10398. (Pubitemid 37071889)
41. J.S. Lee, M.J. Fackler, J.H. Lee, C. Choi, M.H. Park, J.H. Yoon, Z. Zhang and S. Sukumar, Basal-like breast cancer displays distinct patterns of promoter methylation, Cancer Biol Ther 9 (2010), 1017-1024.